Cellular recognition and HLA restriction of a midsequence HBsAg peptide in hepatitis B vaccinated individuals
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
Prediction of protein antigenic determinants from amino acid sequences.
1981 • 3,715 citations
Two populations of Ia-like molecules on a human B cell line.
1980 • 1,112 citations
Role of MHC Gene Products in Immune Regulation
1981 • 705 citations
Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.
1983 • 701 citations
Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.
1982 • 600 citations
Genetic Prediction of Nonresponse to Hepatitis B Vaccine
1989 • 407 citations
Detection of a novel human class II HLA antigen
1983 • 387 citations
The Cell Biology of Antigen Processing and Presentation
1991 • 349 citations
Enhanced Immunogenicity of the Pre-S Region of Hepatitis B Surface Antigen
1985 • 323 citations
Nonresponsiveness to Hepatitis B Vaccine in Health Care Workers
1986 • 218 citations
The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
1992 • 165 citations
AFFINITY OF ANTIBODY RESPONSES IN MAN TO HEPATITIS B VACCINE DETERMINED WITH SYNTHETIC PEPTIDES
1984 • 158 citations
Alloantigen Recognition Is Preceded by Nonspecific Adhesion of Cytotoxic T Cells and Target Cells
1986 • 145 citations
Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.
1982 • 125 citations
The cellular basis for lack of antibody response to hepatitis B vaccine in humans.
1991 • 125 citations
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
1982 • 120 citations
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
1982 • 111 citations
Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides.
1988 • 107 citations
Australia Antigen (Hepatitis B Antigen): A Conformational Antigen Dependent on Disulfide Bonds
1972 • 106 citations
Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells
1988 • 74 citations
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
1984 • 70 citations
The Biochemistry and Cell Biology of Antigen Processing
1988 • 59 citations
Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs.
1981 • 53 citations
HLA‐Bw54‐DR4‐DRw53‐DQw4 haplotype controls nonresponsiveness to hepatitis‐B surface antigen ‐via CD8‐positive suppressor T cells
1990 • 49 citations
Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule
1989 • 48 citations
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). II. Qualitative characteristics of the humoral immune response to the a, d, and y determinants of HBsAg.
1983 • 41 citations
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). VI. T cell fine specificity.
1985 • 38 citations
Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). III. Circumvention of nonresponsiveness in mice bearing HBsAg nonresponder haplotypes.
1983 • 32 citations
Human Immunogenetics: Basic Principles and Clinical Relevance
1990 • 9 citations
Immunogenetic Analysis of the Immune Response to Hepatitis B Virus Antigens
2020 • 5 citations
Appraisal and prospects of a dimeric synthetic peptide coupled with tetanus toxoid for a bifunctional vaccine against hepatitis B virus infection.
1983 • 3 citations